Methyl2-Hydroxy-4-iodobenzoate CAS:18179-39-0
Catalog Number | XD95533 |
Product Name | Methyl2-Hydroxy-4-iodobenzoate |
CAS | 18179-39-0 |
Molecular Formula | C8H7IO3 |
Molecular Weight | 278.04 |
Storage Details | Ambient |
Product Specification
Appearance | White powder |
Assay | 99% min |
Methyl 2-hydroxy-4-iodobenzoate, also known as methyl 4-iodosalicylate, is an organic compound with several interesting effects and applications.One notable effect of methyl 2-hydroxy-4-iodobenzoate is its ability to act as a versatile building block in organic synthesis. The compound contains an ester group and a phenolic hydroxyl group, both of which can undergo various chemical transformations. These functional groups allow chemists to introduce different chemical moieties into the molecule, making it a valuable starting material for the synthesis of complex organic compounds.In addition to its utility in organic synthesis, methyl 2-hydroxy-4-iodobenzoate displays considerable biological activity. It has been shown to exhibit antiproliferative properties against cancer cells. Studies have demonstrated that the compound can inhibit the growth of various cancer cell lines, including breast, lung, and colon cancer cells. Further research is being conducted to better understand the mechanism of action and potential therapeutic applications of this compound in cancer treatment.Another interesting effect of methyl 2-hydroxy-4-iodobenzoate is its role as a ligand in coordination chemistry. The iodine atom present in the molecule can coordinate to transition metal ions, forming metal complexes. These complexes have been studied for their catalytic properties in various reactions, such as C-C and C-N bond formation. The coordination chemistry of methyl 2-hydroxy-4-iodobenzoate provides opportunities for the design and synthesis of novel metal-based catalysts with tailored reactivity.Furthermore, methyl 2-hydroxy-4-iodobenzoate has been investigated for its potential as a photosensitizer in photodynamic therapy (PDT) for cancer treatment. PDT is a non-invasive therapeutic approach that involves the activation of photosensitizing compounds by light of a specific wavelength. The activated photosensitizers generate reactive oxygen species, which can induce cell death in cancer cells. Methyl 2-hydroxy-4-iodobenzoate has shown promising phototoxicity against cancer cells when activated by light, making it a potential candidate for further development in this field.It is important to note that, like any chemical compound, methyl 2-hydroxy-4-iodobenzoate should be handled and used with proper safety precautions. It is advisable to consult safety data sheets and follow any applicable guidelines when working with this compound to ensure safe handling and storage.In summary, methyl 2-hydroxy-4-iodobenzoate exhibits diverse effects and applications in organic synthesis, cancer research, coordination chemistry, and photodynamic therapy. Its versatile functional groups, biological activity, and potential as a photosensitizer make this compound an intriguing molecule for further exploration in various scientific fields.